JP2021532155A5 - - Google Patents
Info
- Publication number
- JP2021532155A5 JP2021532155A5 JP2021504826A JP2021504826A JP2021532155A5 JP 2021532155 A5 JP2021532155 A5 JP 2021532155A5 JP 2021504826 A JP2021504826 A JP 2021504826A JP 2021504826 A JP2021504826 A JP 2021504826A JP 2021532155 A5 JP2021532155 A5 JP 2021532155A5
- Authority
- JP
- Japan
- Prior art keywords
- bladder
- throspium
- pharmaceutical composition
- individual
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024121447A JP2024164020A (ja) | 2018-08-01 | 2024-07-26 | トロスピウムを使用した過活動膀胱の治療方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713414P | 2018-08-01 | 2018-08-01 | |
| US62/713,414 | 2018-08-01 | ||
| US201962850481P | 2019-05-20 | 2019-05-20 | |
| US62/850,481 | 2019-05-20 | ||
| PCT/US2019/044478 WO2020028554A1 (en) | 2018-08-01 | 2019-07-31 | Methods of treating overactive bladder using trospium |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024121447A Division JP2024164020A (ja) | 2018-08-01 | 2024-07-26 | トロスピウムを使用した過活動膀胱の治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021532155A JP2021532155A (ja) | 2021-11-25 |
| JP2021532155A5 true JP2021532155A5 (enExample) | 2022-08-10 |
Family
ID=69232612
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504826A Pending JP2021532155A (ja) | 2018-08-01 | 2019-07-31 | トロスピウムを使用した過活動膀胱の治療方法 |
| JP2024121447A Pending JP2024164020A (ja) | 2018-08-01 | 2024-07-26 | トロスピウムを使用した過活動膀胱の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024121447A Pending JP2024164020A (ja) | 2018-08-01 | 2024-07-26 | トロスピウムを使用した過活動膀胱の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11464734B2 (enExample) |
| EP (1) | EP3829582A4 (enExample) |
| JP (2) | JP2021532155A (enExample) |
| KR (1) | KR20210039403A (enExample) |
| CN (1) | CN112839653A (enExample) |
| AU (1) | AU2019315957A1 (enExample) |
| BR (1) | BR112021001337A2 (enExample) |
| CA (1) | CA3107461A1 (enExample) |
| MX (1) | MX2021001264A (enExample) |
| WO (1) | WO2020028554A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150250717A1 (en) | 2014-03-06 | 2015-09-10 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine |
| US10857173B2 (en) | 2017-07-25 | 2020-12-08 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| JOP20200124A1 (ar) | 2017-11-08 | 2020-05-20 | Taris Biomedical Llc | طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك |
| KR20210039403A (ko) | 2018-08-01 | 2021-04-09 | 타리스 바이오메디컬 엘엘씨 | 트로스피움을 사용한 과민성 방광의 치료 방법 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2125696T3 (es) * | 1996-11-27 | 1999-03-01 | Pfleger R Chem Fab | Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales. |
| MX2013000002A (es) * | 2001-07-27 | 2013-04-29 | Teva Womens Health Inc | Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva. |
| US20060058777A1 (en) | 2002-12-11 | 2006-03-16 | Pia Norup Nielsen | Urinary catheter device with a pharmaceutically active composition |
| CA2513188A1 (en) | 2003-01-16 | 2004-08-05 | University Of Rochester | Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| CA2552677A1 (en) * | 2004-01-13 | 2005-07-28 | Vasogenix Pharmaceuticals, Inc. | Controlled release cgrp delivery composition for cardiovascular and renal indications |
| ES2322148T3 (es) | 2004-08-11 | 2009-06-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias. |
| US20060128808A1 (en) * | 2004-10-20 | 2006-06-15 | Galderma Research & Development, S.N.C. | Method of using adapalene in acne maintenance therapy |
| US20060217405A1 (en) | 2005-03-17 | 2006-09-28 | Indevus Pharmaceuticals, Inc. | Interstitial cystitis treatment |
| US7390816B2 (en) * | 2005-06-21 | 2008-06-24 | Bridge Pharma, Inc. | Methods for treating urinary incontinence in patients suffering from memory disorders |
| JP5265359B2 (ja) | 2005-08-11 | 2013-08-14 | マサチューセッツ インスティテュート オブ テクノロジー | 膀胱内薬物送達デバイスおよび方法 |
| RU2435610C2 (ru) | 2005-09-02 | 2011-12-10 | Теравида, Инк. | Терапия для лечения заболевания |
| EP1967202A1 (en) | 2007-03-05 | 2008-09-10 | AEterna Zentaris GmbH | Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity |
| US9586035B2 (en) | 2007-12-11 | 2017-03-07 | Massachusetts Institute Of Technology | Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens |
| EA201170297A1 (ru) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| AU2010265863C1 (en) | 2009-06-26 | 2012-11-01 | Taris Biomedical Llc | Implantable drug delivery devices and methods of making the same |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| AU2010339821B2 (en) | 2009-12-17 | 2015-02-19 | Taris Biomedical Llc | Implantable device with intravesical tolerability and methods of treatment |
| SMT202000670T1 (it) | 2010-08-05 | 2021-01-05 | Taris Biomedical Llc | Dispositivo e kit di somministrazione di farmaci per stent ureterale |
| JP5945544B2 (ja) | 2010-10-06 | 2016-07-05 | タリス バイオメディカル エルエルシー | 時間選択的に生体吸収可能または崩壊可能な薬剤送達システムおよび方法 |
| CA2823783C (en) | 2011-01-10 | 2023-03-21 | Taris Biomedical, Inc. | Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding |
| RU2598057C2 (ru) | 2011-02-04 | 2016-09-20 | ТАРИС Биомедикал ЛЛК | Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью |
| SI2890384T1 (sl) * | 2012-08-31 | 2022-02-28 | Taris Biomedical Llc | Sistemi za dostavo zdravila in postopki za zdravljenje raka sečnega mehurja, ki obsegajo oksaliplatin |
| BR112015004110A2 (pt) | 2012-08-31 | 2017-07-04 | Taris Biomedical Llc | sistemas e métodos de distribuição de drogas para tratamento de próstata |
| SG11201502104YA (en) * | 2012-09-18 | 2015-05-28 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder voiding dysfunction and other lower urinary tract disorders by using trospium |
| EP2719374A1 (en) | 2012-10-12 | 2014-04-16 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Drug delivery device |
| EP2964310A1 (en) | 2013-03-05 | 2016-01-13 | TARIS Biomedical LLC | Drug delivery devices and methods for controlled drug release through device orifice |
| HUE072250T2 (hu) | 2013-03-15 | 2025-11-28 | Taris Biomedical Llc | Gyógyszeradagoló eszközök gyógyszeráteresztõ résszel |
| US9814671B2 (en) | 2013-03-15 | 2017-11-14 | Taris Biomedical Llc | Drug delivery devices and methods for drug delivery |
| ES2956840T3 (es) | 2013-08-19 | 2023-12-29 | Taris Biomedical Llc | Dispositivos de administración de fármacos de múltiples unidades |
| CA2929554A1 (en) | 2013-11-05 | 2015-05-14 | Taris Biomedical Llc | Osmotic drug delivery devices, kits, and methods |
| US20150250717A1 (en) | 2014-03-06 | 2015-09-10 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer with gemcitabine |
| US10737078B2 (en) | 2014-06-26 | 2020-08-11 | Taris Biomedical Llc | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems |
| KR102658706B1 (ko) | 2015-04-23 | 2024-04-17 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 성분을 구비한 약물 전달 장치 및 방법 |
| EP3347036A1 (en) * | 2015-09-10 | 2018-07-18 | Assistance Publique - Hôpitaux de Paris | Use of interleukin 2 for treating spondyloarthritis |
| JP6283440B1 (ja) * | 2016-10-27 | 2018-02-21 | Ｅａファーマ株式会社 | 逆流性食道炎の再発抑制剤 |
| SMT202100310T1 (it) | 2017-02-01 | 2021-07-12 | Taris Biomedical Llc | Dispositivi per la deposizione di farmaci in vivo |
| US10857173B2 (en) | 2017-07-25 | 2020-12-08 | Taris Biomedical Llc | Methods of treating tumor metastasis |
| KR20210039403A (ko) | 2018-08-01 | 2021-04-09 | 타리스 바이오메디컬 엘엘씨 | 트로스피움을 사용한 과민성 방광의 치료 방법 |
-
2019
- 2019-07-31 KR KR1020217005331A patent/KR20210039403A/ko not_active Ceased
- 2019-07-31 CA CA3107461A patent/CA3107461A1/en active Pending
- 2019-07-31 AU AU2019315957A patent/AU2019315957A1/en not_active Abandoned
- 2019-07-31 WO PCT/US2019/044478 patent/WO2020028554A1/en not_active Ceased
- 2019-07-31 CN CN201980064872.5A patent/CN112839653A/zh active Pending
- 2019-07-31 JP JP2021504826A patent/JP2021532155A/ja active Pending
- 2019-07-31 US US16/528,032 patent/US11464734B2/en active Active
- 2019-07-31 BR BR112021001337-7A patent/BR112021001337A2/pt unknown
- 2019-07-31 EP EP19844186.7A patent/EP3829582A4/en active Pending
- 2019-07-31 MX MX2021001264A patent/MX2021001264A/es unknown
-
2022
- 2022-08-11 US US17/886,325 patent/US12133913B2/en active Active
-
2024
- 2024-07-26 JP JP2024121447A patent/JP2024164020A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Munro et al. | Maintenance treatment with cyclosporin in atopic eczema | |
| Arshinof et al. | Use of topical nonsteroidal anti-inflammatory drugs in excimer laser photorefractive keratectomy | |
| MX2022007276A (es) | Tratamiento de la esclerosis amiotrofica lateral y enfermedades relacionadas. | |
| US20160317468A1 (en) | Uses of cannabidiol for treatment of infantile spasms | |
| Berth‐Jones et al. | Benign familial chronic pemphigus (Hailey‐Hailey disease) responds to cyclosporin | |
| Reisch et al. | Use of angiotensin-converting enzyme inhibitors for the preservation of kidney function | |
| US20190083388A1 (en) | Synthentic transdermal cannabidiol for the treatment of focal epilepsy in adults | |
| IL315023A (en) | Neuroactive steroids for treatment of cns-related disorders | |
| US12084491B2 (en) | Treatment of Parkinson's disease | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2022546456A5 (enExample) | ||
| JP2024056908A (ja) | デュラグルチドを使用する方法およびデュラグルチドを含有する組成物 | |
| KR20070011276A (ko) | 쿠에티아핀 항정신병제를 사용한 정신병의 치료 | |
| KR102843222B1 (ko) | 마이크로조말 트리글리세라이드 전달 단백질 억제제의 섬유화 질환 치료 용도 | |
| CN120284871B (zh) | 用于鼻腔的含奥洛他定与溴莫尼定的复方制剂组合物及其制备方法 | |
| JP2019531286A (ja) | Ｃｈｓ−１３１による多発性硬化症の治療 | |
| CA2506481A1 (en) | Method of treatment of conditions by administration of streptolysin o | |
| KR20170118830A (ko) | 조현병의 치료를 위한 일로페리돈 | |
| XUAN et al. | Efficacy of oxymetazoline eye drops in non-infectious conjunctivitis, the most common cause of acute red eyes | |
| Fujishima et al. | Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis | |
| US20190321325A1 (en) | Method for treating multiple sclerosis | |
| CN1290166A (zh) | 运动障碍的治疗 | |
| EP3167881B1 (en) | Locally administered ethamsylate as a medicament | |
| Cocco et al. | Initiating foslevodopa infusion in Parkinson disease: a pragmatic study | |
| WO2006130769A3 (en) | Methods for treatment of growth disorders |